PCBs In Human Milk Research Articles

Determination of PCDD/Fs, PBDD/Fs and dioxin-like PCBs in human milk from mothers residing in the rural areas in Flanders, using the CALUX bioassay and GC-HRMS

Since the CALUX (Chemically Activated LUciferase gene eXpression) bioassay is a fast and inexpensive tool for the determination of dioxin-like compounds in a large number of samples and requires only small sample volumes, the use of this technique in human biomonitoring programs provides a good alternative to GC-HRMS. In this study, a new CALUX method for the separate analysis of PCDD/Fs and dioxin-like PCBs (dl-PCBs) in small amounts of human milk samples with the new sensitive H1L7.5c1 cell line was used to analyze 84 human milk samples, collected from mothers residing in the Flemish rural communities. The geometric mean CALUX-Bioanalytical Equivalent (CALUX-BEQ) values, reported for the 84 mothers from the study area were 10.4 (95% CI: 9.4–11.4) pg CALUX-BEQ per gram lipid or 0.41 (95% CI: 0.37–0.45) pg CALUX-BEQ per gram milk for the PCDD/Fs and 1.73 (1.57–1.91) pg CALUX-BEQ per gram lipid or 0.07 (95% CI: 0.06–0.08) pg CALUX-BEQ per gram milk for the dioxin-like PCBs. Multiple regression analysis showed significant associations between PCDD/Fs and weight change after pregnancy, smoking and consumption of local eggs. One pooled human milk sample was analyzed with both CALUX and GC-HRMS. The ratio of CALUX and GC-HRMS results for this sample were respectively 1.60, 0.58 and 1.23 for the PCDD/Fs, the dl-PCBs and the sum of both fractions, when using the 2005-TEF values. Additionally, also low levels of certain brominated dioxins and furans were detected in the pooled sample with GC-HRMS.

Levels of PCDDs, PCDFs, and dioxin-like PCBs in human milk among Hong Kong mothers

Dioxins are a family of persistent organic pollutants (POPs) listed under the Stockholm Convention, and include PCDDs, PCDFs, and dioxin-like PCBs. These toxic chemicals are carcinogenic, widely dispersed, and have long half-lives. They have contaminated the food web and, being fat-soluble, accumulate in adipose tissues and milk in the human body. To assess human exposure, we collected breast milk samples from 137 first-time mothers recruited from around Hong Kong. Samples were analysed by HRGC–HRMS in four pools, according to the subject's age and length of residency. Exposure was related to age, duration of stay, and possibly diet. Generally, older mothers, and mothers with a longer stay in Hong Kong, had higher levels of dioxins in their milk. This pattern was clearest for the PCBs, although deviations were observed for some of the PCDD/Fs. Mean concentrations, measured per gram of lipid weight in terms of WHO toxic equivalents (WHO-TEQs), were 7.48pg/g for PCDD/Fs and 3.79pg/g for PCBs, giving a total of 11.27pg/g for PCDD/Fs and PCBs combined. Compared to an earlier Hong Kong study we conducted in 2002, the mean WHO-TEQ values in our latest findings were about 9% lower overall for PCDD/Fs and 19% lower for PCBs, with the mean total WHO-TEQ for PCDD/Fs and PCBs being around 13% lower in this study. This indicates a general declining trend in the levels of POPs in Hong Kong. However, our levels were still high when compared to those in some other Asian-Pacific countries. More stringent policies on reducing and eliminating POPs should help to lower these. Continued surveillance for POPs in human milk, as well as in common foodstuffs, will provide us with important information on human exposures that will be necessary for tracking our progress, and making future health risk assessments.

PCDD/Fs and dioxin-like PCBs in human milk and estimation of infants’ daily intake: A review

This paper reviews the recent scientific literature on PCDDs, PCDFs and dioxin-like PCBs in human milk. All the papers reporting levels of these contaminants in human breast milk published from January 2000 to January 2009 and available on the www.sciencedirect.com web site were identified and included. The aim was (1) to study levels of PCDDs, PCDFs and PCBs in human milk in mothers from different geographical areas and assess infant exposure to these contaminants; (2) to study the effect of variables such as the mother’s age, number of deliveries, dietary and smoking habits and her own nutrition in infancy, and the environment, on levels of the contaminants in breast milk; (3) to study time patterns, and (4) to identify data gaps.

Ratio variation of congener profiles of PCDD/Fs and dioxin-like PCBs in human milk during lactation

This study investigates the compositional variations, changes in concentrations and contribution of particular congeners of PCDDs, PCDFs, non-ortho PCBs and mono-ortho PCBs in human milk from two mothers sampled during the 12-month lactation period. Total PCDD/F and dioxin-like PCB concentration in milk sampled from the primiparous mother on day 5 after delivery was 37pgTEQ/g fat, and this value decreased significantly by 43% at 12months. In milk sampled from the multiparous mother nursing her second child on day 5 after delivery was 12pgTEQ/g fat, and this value decreased by 40% at 12months. The decrease was statistically significant not for PCDD/Fs, but for dioxin-like PCBs. The ratio variance of the congener profiles of PCDD/Fs and dioxin-like PCBs in the milk remained similar during lactation. Moreover, the congener profiles of PCDD/Fs and dioxin-like PCBs in the milk showed similar percentages for both mothers independent of the lactation event and the number of previous births. The mean daily intake of dioxins by the infant nursed by the primiparous mother and the infant nursed by the multiparous mother up to six months of age was 140 and 46pg TEQ/kg body weight, respectively. From seven to twelve months of age, the mean daily intake was 37 and 13pg TEQ/kg body weight, respectively. Both values decreased by approximately 70%. The reasons why the mothers' body burden of dioxins decreased by breastfeeding and why the infants' daily intake of human milk per body weight decreased as the infant grows older consequently decreased were considered.

Body burden of POPs of Hong Kong residents, based on human milk, maternal and cord serum

This study is one of the very few investigating the body burdens of persistent organic pollutants in residents of Hong Kong. Twenty-nine human milk samples and 21 human blood (and cord blood) samples collected from 2005 were analyzed for PAHs, OCPs and PCBs levels. Higher levels of PAHs, DDTs and PCBs were detected in human milk samples when compared to maternal serum and cord serum (PAHs: milk: 1981 ng g − 1 fat, maternal serum: 1461, cord serum: 1158; DDTs: 3099, 1934, 1556; PCBs: 49, 41, 40). Among the 16 PAHs, naphthalene (human milk: 786 ng g − 1 fat, maternal serum: 331, cord serum: 348), phenanthrene (361, 144, 193), pyrene (187, 154, 98) and fluoranthene (158, 128, 89) were the major PAHs detected in three human tissues. p,p'-DDE and p,p'-DDT were the only metabolites of DDT detected in the three types of human tissues. High detection rate of the p,p'-DDE and p,p'-DDT (> 90%) were noted in the three types of human samples. On the contrary, low detection frequency of PCBs in human milk (10.7%), maternal serum (1.7%) and cord serum (0.8%) were observed. The correlation coefficients of the PAHs, DDTs and PCBs levels in the three types of human tissues together with fish consumption, maternal age and tissue fat were analyzed. The following significant correlations were observed: Σ DDTs and p,p'-DDE in human milk with consumption of freshwater and marine fish, and maternal age; Σ PCBs in human milk with marine fish consumption, and maternal age; Σ PAHs in human milk with maternal age, respectively. The estimated daily intakes of DDTs by infants indicated that 7 out of 29 of the human milk samples exceeded 20 ng g − 1 day − 1 , the tolerable daily intake (TDI) proposed by the Health Canada Guideline in terms of DDTs levels. The high intake of DDTs by infants may be of concern as infants are more susceptible to the adverse effects imposed by various environmental contaminants. Human milk is a reliable and comparatively non-invasive tool for monitoring body loading of POPs, which also allows health risk assessment of residual chemicals on our next generation.

Organochlorine pesticide and polychlorinated biphenyl residues in human milk from the Southern Coast of Caspian Sea, Iran

In the present study, human milk was sampled in October 2006 from Nour and Noushahr cities and their countryside on the Southern Coast of Caspian Sea, Iran. They were analyzed for organochlorine pesticides, such as dichlorodiphenyltrichloroethane (DDT) and its metabolites, hexachlorobenzene (HCB), α, β and γ-hexachlorocycloexane (HCH) isomers and six PCBs congeners (IUPAC Nos. 28, 52, 101, 138, 153 and 180). Average concentrations of HCHs, DDTs, PCBs and HCB were 3780, 2554, 1560 and 930 ng g −1 lipid wt, respectively. There was no significant difference between the concentrations of investigated pollutants between the two cities and their countryside. No significant differences in OCPs and PCBs were found between primiparous and multiparous mothers. There was no correlation between levels of OCPs and PCBs in human milk and the age of mothers. There was a significant difference in the organochlorine levels, including DDTs, between mothers who have eaten fish once a week and those who consumed fish more than once ( p > 0.05). An analysis of the infant exposure to OCPs and PCBs via breast milk indicated that the daily intake rates for most of the mothers were above the guideline proposed by Health Canada which is definitely caused on children health for concern.

Biomonitoring of PCBs in Human Milk and Blood Serum of the Czech Population

Biomonitoring of PCBs in Human Milk and Blood Serum of the Czech Population

Application of a Novel Large-Volume Injection Method Using a Stomach-Shaped Inlet Liner in Capillary Gas Chromatographic Trace Analysis of Dioxins in Human Milk and Plasma

A newly developed large-volume injection (LVI) technique that employs a unique stomach-shaped inlet liner (SSIL) inside of a programmable temperature vaporizer was used for the determination of trace amounts of dioxins in human milk and plasma. The initial temperature and the initial dwelling time of the inlet and the kind of solvent used were found to be critical in determining the analytical sensitivity of dioxins due to the loss of these relatively volatile compounds during solvent vaporization. Human milk and plasma were purified and fractionated by pre-packed multi-layered silica-gel chromatography and activated carbon silica-gel column chromatography. A 20-microL aliquot of the fraction collected from the chromatography with toluene was directly applied to the LVI system in high-resolution gas chromatography/high-resolution mass spectrometry. Excellent correlation (r > 0.97) between the values obtained by the LVI method using the SSIL device and those by the conventional regular-volume splitless injection method was obtained for PCDDs, PCDFs and non-ortho PCBs in human milk and plasma samples.

A Review of Environmental Exposure to Persistent Organochlorine Residuals During the Last Fifty Years

Environmental exposure to persistent toxic organochlorines (Pesticides and Polychlorinated biphenyls) is ever changing over time and space, as a result of their agricultural and industrial use and the control measures being adopted. Scientific investigations have revealed the great toxicity of these compounds and their severe impact on human health so that it is quite important to evaluate the risk of human exposure to these toxic compounds by means of a biomarker, such as human milk. The determination of persistent organochlorine compounds in human milk permits the monitoring (time-place) of these toxicants in the human body after its environmental exposure. For this reason, we have reviewed different papers published over the past 50 years in different countries and continents to find out the dynamics of exposure to persistent organochlorine residuals. Scientific progress in analytical methods and toxicological mechanisms, which are changing due to the discovery of certain compounds together with the use and introduction of derived products and the establishment of sanitary measures, has caused a succession of publications on pesticides and PCBs in human milk. These have reflected exposure to these compounds, their great persistence, and the correlation of the levels detected with diverse epidemiological factors (age, profession, number of children, number of them breast fed, residence in rural or urban areas, etc.) with the aim of establishing their association and the effectiveness of protection measures. Our review found that the greatest number of publications on this topic were from European countries, but the trend in these determinations was seen to be similar on the other continents (America, Asia and Africa) with a clear reduction in the levels of organochlorine residuals (Pesticides and PCBs) in human milk. These levels served as biomarkers (time-place) suggesting that the control and prohibition of their use would minimize their impact on public health.

PCBs and OCPs in human milk and selected foods from Luqiao and Pingqiao in Zhejiang, China

This study was conducted to measure the levels of 23 PCB congeners and 6 organochlorine pesticides (OCPs) in human milk and three food types collected from Luqiao and Pingqiao in Zhejiang Province, China. An effort was also made to explore the potential health risk for the mothers and breast-fed infants living in these two localities. Luqiao was selected as the sampling site because it is the largest place for the disassembly of obsolete transformers and electrical waste in China. Pingqiao, located 100 km NW of Luqiao, is not known to be a place for any electronic or electrical waste and hence was chosen as the control site. Both localities are important agricultural places in the province. The organochlorines were measured in the samples using the GC-muECD technique. Micro-EROD bioassay method was also used as a complement of the chemical analysis to estimate the TEQ levels of dioxin-like PCBs in human milk. The data showed that the human milk, rice, hen egg, and fish samples from Luqiao were more heavily contaminated with PCBs than those from Pingqiao, suggesting that the mothers and their breast-fed infants in Luqiao tended to receive greater exposure to PCBs than those living in Pingqiao. The OCP levels in the two localities were found comparable, suggesting that the major source of contamination with these pesticides was from their agricultural uses. Significant correlation (R2 = 0.87, P<0.001) of PCB TEQs was found between the bioassay and chemical analysis method, suggesting that micro-EROD is an effective method for comprehensive determination of TEQ levels in human milk. Comparison with literature data showed that the PCB levels in milk samples from Luqiao were significantly higher than those from localities in other Chinese provinces and comparable to those in developed or industrialized countries.

Dioxins in human milk and smoking of mothers

The relation between the levels of dioxins in human breast milk and the smoking habits of the mothers is controversial. To clarify this relationship, we analyzed data from the human milk survey in Japan. The human milk survey has been conducted in Japan since 1997. Healthy pregnant women aged 20-39 years were recruited and 50 ml of breast milk was collected from them at 30 days after delivery. PCDDs, PCDFs, and dioxin-like PCBs were measured by using GC/MS. The smoking habits of the mothers were established by interviewing them soon after delivery and were classified into four categories: current smokers, ever smokers who quit smoking at the pregnancy, ever smokers who quit smoking before the pregnancy, and never smokers. The levels of dioxins in breast milk were compared in the four categories of smoking among 853 primiparas. In addition, we analyzed the association between dioxin levels and passive smoking among never smokers. The geometric means of the dioxin concentrations were calculated in order to compare the differences between dioxins. The geometric means of dioxin-like PCBs in milk of never smokers was the highest (9.2 pg TEQ/g fat); followed by ever smokers who quit smoking before the pregnancy, ever smokers who quit smoking at the pregnancy, and current smokers (7.5, 7.2, and 6.6 pg TEQ/g fat, respectively). The differences between these levels were statistically significant (ANOVA, p<0.001). No significant difference was observed between the level of dioxins in milk from never smokers subjected to passive smoking status and those who had not experienced passive smoking. The levels of dioxin-like PCBs in human milk were negatively related to the smoking habits of mothers.

WHO GLOBAL ENVIRONMENT MONITORING SYSTEM/FOOD CONTAMINATION MONITORING AND ASSESSMENT PROGRAMME (GEMS/FOOD) – WHO/UNEP COORDINATED GLOBAL SURVEY OF HUMAN MILK FOR PERSISTENT ORGANIC POLLUTANTS (POPs)

ISEE-450 Introduction: Over the past decades, GEMS/Food has collected information on the levels and time-trends of many POPs in food, including human milk. GEMS/Food is currently supporting the development of regional total diet studies to assess exposure to contaminants in foods as consumed, and most of the twelve POPs will be included in these studies. Over the last 20 years, the WHO has sponsored three special surveys of dioxins, dibenzofurans and dioxin-like PCBs in human milk. Article 16 of the Stockholm Convention on POPs requires an effectiveness evaluation of the convention four years after its ratification. A series of meetings, convened by the United Nations Environment Programme (UNEP): Chemicals on this issue, have recommended that human milk be one of the media to be monitored, and have urged close collaboration between UNEP and the WHO in its implementation. Methods: GEMS/Food, in collaboration with the State Laboratory for Chemical and Veterinary Drug Analysis of Food in Freiburg, Germany, has completed a pilot study of human milk, to assess the feasibility of measuring all twelve POPs presently covered under the Stockholm Convention. In order to obtain reliable and comparable results, a Protocol for Collection, Handling and Analysis of Samples at the Country Level has been revised, in view of the WHO/UNEP proposed Coordinated Global Survey of Human Milk for POPs. This protocol has been designed based on the advice of experts in the field and on extensive experience of certain countries in undertaking similar surveys using human samples, including human milk. Results: The pilot study of human milk confirmed the feasibility of measuring all twelve POPs presently covered under the Stockholm Convention, in a single human milk sample, by application of additional analytical steps. This study also included polybrominated biphenylethers. The revised protocol presents an overview of the proposed survey, including criteria for the selection of donors, the donor questionnaire, collection of individual and pooled samples, and transport, preparation and analyses of samples. Data handling and assessment considerations are also addressed and ethical issues, like informed consent of donors and promotion of breastfeeding, are major considerations in this protocol. Conclusion: The WHO GEMS/Food Programme which maintains links to UNEP, FAO, IAEA and IPCS, is the most important global monitoring programme with relevance to POPs and other food contaminants. The revised protocol for collection, handling and analyses of human milk samples is intended to provide guidance to all countries that have ratified the Stockholm Convention, especially in regard to Article 16, and to countries that have taken part in previous GEMS/Food studies of human milk for POPs. This protocol will serve as the basis for national assessments, as part of a global survey of human milk for POPs. In order to promote reliability and comparability, countries are encouraged to adhere to this protocol, as closely as possible.

Effects of Aroclors and individual PCB congeners on activation of the human androgen receptor in vitro

To investigate possible interactions between the human androgen receptor and PCBs in vitro, we have used a previously characterized human androgen receptor reporter gene assay in which PC-3 LUC AR+ cells respond to 5α-dihydrotestosterone (DHT, 50 pM) with enhanced luciferase activity. The effects of Aroclors, commercial mixtures of PCBs, or polychlorinated terphenyls (PCTs) (0, 0.1, 1.0, and 10.0 μM) on luciferase activity in PC-3 LUC AR+ cells were determined after exposure for 18 h in the presence and absence of DHT (50 pM). In the absence of DHT, none of the Aroclors induced luciferase activity but, in the presence of DHT (50 pM), Aroclors 1016, 1221, 1232, 1242, 1248, 1254, 1260, 5432, and 5442 acted antagonistically at concentrations that did not affect cell viability. Aroclor 5460 was without effect. Similarly, when PCBs found as human milk contaminants were assessed as individual congeners (each at 1 μM, where no cytotoxic effects were observed), none activated luciferase expression in the absence of DHT but PCBs 49, 66, 74, 105, and 118 completely antagonized the stimulation by DHT (50 pM) and PCBs 138, 153, and 156 were less effective antagonists, reducing the DHT stimulation by about 50%. Thus, 30% (by weight) of the PCBs in human milk are androgen antagonists (PCBs 66, 74, 105, and 118) and a further 25% are partial antagonists (PCBs 138, 153, and 156). A proportionally representative mixture of PCBs that contaminate human milk also caused the DHT-mediated activation of luciferase activity in PC-3 LUC AR+ cells to be reduced by more than 50%.

Levels and trends of PCDD/Fs and PCBs in human milk in Finland

Word Health Organization, WHO/EURO, has coordinated two rounds of follow-up studies on levels of PCDDs, PCDFs, and PCBs in human milk which were analyzed as two pooled samples from each participating country, one from urban and the other one from rural area. Finland has taken part to both of those studies and we are now reporting results of all the second round randomly sampled human milk samples (84 samples) from Southern (20) and Eastern (64) Finland. The levels of PCDD/Fs and PCBs in human milk in Southern Finland were considerably higher than in Eastern Finland. The level of PCDD/Fs in human milk in Southern Finland was the same as in the Central Europe but the level in Eastern Finland was similar to levels in Norway and eastern parts of Europe. The concentrations of PCDD/Fs and PCBs showed a significant decrease from 1987 to 1994. Declining of PCDD/Fs and PCBs was 36 and 49 % in primiparae mothers' milk, respectively. This decrease in concentrations of PCDD/F and PCB was slightly greater in Eastern than in Southern Finland.

Congener-specific analysis of PCBs in human milk from Kazakhstan

We have characterized the spectrum of PCB contaminants in human milk samples from 95 women in Kazakhstan using GC/MS congener specific analysis. In these samples, 12 PCBs comprised 83% of total PCB concentration, and were similar to the major PCBs reported in other published human milk studies. By summing concentration levels of 80 PCB congeners in the Kazakhstan samples, a mean total PCB concentration of 368 ng/g fat was obtained. This is lower than levels reported in human milk samples from Western Europe. Six indicator PCBs were summed in Kazakh milk samples; their aggregate value was similar to literature values published for human milk from the former Soviet Union. Using WHO's recent TEF scheme, the mean sum of PCDD/F, coplanar PCB, mono-ortho PCB, and di-ortho PCB TEQ is 42 pg TEQ/g fat.

Organochlorine pesticides and PCBs in human milk collected from mothers nursing hospitalized children

Organochlorine compounds in milk were analyzed in samples collected over a nine-year period (1987–1995) from nursing mothers (N=139) whose children were hospitalized for various disorders. All samples contained p,p′-DDE and PCBs; the median concentrations were 318 μg/kg milk fat and 220 μg/kg milk fat resp. Higher levels were found in mothers (N=12) nursing neonates with impaired neurodevelopmental competencies or an inappropriate arousal reaction. No difference was observed between mothers nursing children with respiratory or gastrointestinal diseases, urinary tract infections or other infectious diseases, anemias, prolonged neonatal hyperbilirubinaemias or when children were with dermatological findings, congenital malformations or healthy.

PCDD, PCDF, AND PCB concentrations in human milk from two areas in Finland

Concentrations of 17 toxic 2,3,7,8-chlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs) and of 36 polychlorinated biphenyl congeners (PCBs) were analyzed from 167 randomly sampled human milk samples from Southern (77 samples) and Eastern (90) Finland. The level of PCDD/Fs and PCBs in human milk in Southern Finland was about 25% higher than those from Eastern Finland. The level of PCDD/Fs in human milk in Finland was the same as in Sweden, 30–50 % lower than in milk from Central Europe but about 45% higher than values from Norway or Russia. The PCB concentrations in Southern Finland were at the same level as in the Netherlands, and in Eastern Finland at the same level as in Norway. The levels of PCDD/Fs and PCBs decreased with increasing number of children: the third child was exposed to about 70% of the amount of PCDD/Fs and PCBs as compared with the first child, and the eighth to tenth child to about 20%. The congener patterns of PCDD/Fs and PCBs in Finnish human milk were similar to the countries of Central Europe, however, the levels of penta- and heptachlorinated furans were slightly higher than in milk from other countries.

Organochlorine pesticides, HCB, and PCBs in human milk in Poland.

Persistent organochlorine compounds were used in agriculture and industry for years. Their ability to accumulate in organisms constituting links of the food chain and a unique chemical stability made them a hazardous environmental contaminants. The metabolism and excretion of chlorinated hydrocarbons is a very slow process. One of the most important means of elimination such compounds from the woman`s body is lactation. Consequently, human milk has occasionally a significant concentration of organochlorine compounds. Such compounds are identified in women`s milk all over the world. The objective of this study was to identify organochlorine pesticides, HCB, and PCBs concentrations in human milk in Poland by comparing more and less industrialized regions. 15 refs., 3 tabs.

Individual PCBs as predictors for concentrations of non and mono-ortho PCBs in human milk

32 Dutch human milk samples were analyzed for PCBs with either HRGC-ECD or HRGC-LRMS in the NCI mode. Samples were collected from three different locations in The Netherlands: Amsterdam, Rotterdam and Groningen. Quantitatively, no differences could be observed between the three localities, while in addition the congener specific pattern showed a striking similarity for all individual samples. Only principal component analysis revealed slight individual differences. Based on similarities in the PCB profiles, linear relationships were calculated between 2,3'4,4',5-PnCB (#118) or 2,2'4,4'5,5'HxCB (#153) and the most relevantnon andmonoortho PCBs exhibiting dioxinlike activity. These PCBs included 2,3,3',4,4'-PnCB (#105), 3,3',4,4'5-PnCB (#126) 2,3,3',4,4',5-HxCB (#156), 2,3,3',4,4',5'-HxCB (#157), 2,3',4,4',5,5'-HxCB (#167) and 3,3',4,4',5'5-HxCB (#169).Good linear relationships were observed between individual PCBs. Based on the results of this study, PCB #118 can be used to predict concentrations of the PCBs #105 and #126. PCB #153 can be used as a predictor for the PCBs #156, #157, #167 and #169, but also for the total toxic equivalencies (TEQs) ofnon andmonoortho PCBs present in human milk. This method using certain PCBs as predictors for other toxicological relevant congeners, can be useful and cost effective, e.g. for epidemiological studies. However, before applied a number of conditions should be met. These are: 1) A stable composition of the PCB matrix should be established. 2) A possible time dependent change in composition of the matrix should first be excluded when used over different time periods.

The Dutch PCB/dioxin study Development of a method for the determination of dioxins, planar and other PCBs in human milk

A method for the determination of dioxins, planar PCBs and other PCBs in human milk is described. The work is part of a big Dutch project, (seven institutes participate) in which 400 human milk samples from two areas (Rotterdam and Groningen) taken at two different times (10 and 42 days) after delivery had to be analysed for planar PCBs, dioxins and other PCBs (1st sampling) and only other PCBs (2nd sampling). Planar compounds are determined with GC/HRMS, other PCBs with GC/ECD. As type of analytes for 1st and 2nd sampling are different the method was focussed on these analytes. After fat extraction, clean up was carried out on GPC and alumina columns. Only in case of analysis of planar compounds and other PCBs, chromatography on porous graphitised carbon was carried out after which GC-HRMS (planar compounds) and GC/ECD (other PCBs) was performed; otherwise GC/ECD after alumina clean up was performed. The method is validated through recovery experiments with standards (other PCBs, labelled planar compounds), comparison of results for other PCBs obtained with the two different clean-up procedures, reproducibility of “quality control samples” for planar compounds and blanc chemicals.